Hi Garnev,
Phosphagenic's patented TPM technology, (Targeted Penetration Matrix), is a delivery system that enables the active ingredients to reach deeper into the skin.
Phospha E is like a super vitamin E. It is one of the active ingredients as distinct from their TPM delivery technology. The key benefit of Phospha E compared to normal vitamin E is that Phoshpa E provides a huge boost in bioavailability.
So in effect we have a very powerfull combination happening with Elixia. A delivery systems (TPM) that gets a significantly higher portion of active ingredients into the deeper layers of the skin where they can provide greater benefits with the added kicker that the 'our' active ingredients are supercharged via a phosphorylation technology. Phospha E is the name given to phosphorylated vitamin E. This phosphorylation process is also patented.
Whilst Phosphagenics may or may not sell Phospha E to other Companies the addition of TPM supercharges Elixia and lifts the game to a whole new level.
I could be 100% wrong on this one, at the moment I don't believe Phosphagenics are selling Phospha E to competitors for usage in their rival beauty products.
Check out the December newsletter, it does an excellent job of outlining the key differences that sets Elixia streets ahead of the opposition.
Cheers
Boomer
- Forums
- ASX - By Stock
- elixir,
Hi Garnev,Phosphagenic's patented TPM technology, (Targeted...
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
NEWS
Antler Copper Project hits major permitting milestone – air quality permit advances to final review
NEWS
Breakthrough programs slash healthcare events, driving a significant A$1.8M+ annual revenue boost
Add AVE (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.923M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
35 | 43869108 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 44263580 | 22 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
35 | 43869108 | 0.002 |
16 | 22966742 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 44170247 | 21 |
0.004 | 34681763 | 17 |
0.005 | 16900219 | 10 |
0.006 | 9723435 | 9 |
0.007 | 13229103 | 6 |
Last trade - 16.12pm 04/10/2024 (20 minute delay) ? |
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
AVE (ASX) Chart |
Day chart unavailable